Psychedelic Chocolates, Mislabeling, and Why Animals Are at Risk
Syndrome-based, harm-reduction clinical approaches when substance-specific information is unknown.
Contaminants in psychedelic substances
A recent public health warning involving psychedelic chocolate products — including PolkaDot-branded chocolates — highlights an issue that’s increasingly relevant for veterinary medicine: unregulated, mislabeled, or undisclosed psychoactive ingredients in edible products.
In several cases, products marketed as “psychedelic” or “microdose” chocolates were found to contain psychoactive compounds not listed on the label, including synthetic tryptamines (psilocin, 4-ACO-DET, 4-HO-DET and 4-HO-MET). This means that even the human consuming the product may not actually know what substances — or what doses — are present.
From a veterinary perspective, this matters for a few important reasons.
Animals are not choosing to participate. Most veterinary cases involve accidental ingestion: a dog finds a dropped piece of chocolate, a wrapper is left accessible, or an edible is stored in a place that feels “safe” to a human but isn’t safe for a curious animal.
These products often involve multiple layers of risk:
Chocolate itself (theobromine, caffeine)
Psychoactive compounds acting on serotonin receptors
Unknown dose, substance, or purity
Possible co-exposures (SSRIs, other medications, etc.)
When ingredients are mislabeled or undisclosed, clinicians lose one of the most basic tools we rely on: accurate history.
Guardians may truly believe they know what was ingested — and still be wrong.
Clinical Tools for Ready Response
This is why, at VeterinaryPsy, we emphasize syndrome-based, harm-reduction approaches rather than substance-specific assumptions.
View our free clinical tools here, including a clinical response algorithm. You can keep the live version on your phone or computer and have immediate access to the current veterinary response protocol to psychedelic substance exposure in animals.
Clinically, it matters far less whether a compound is “natural” or “synthetic” than whether it produces:
Serotonergic effects
Hyperthermia
Neurologic changes
Cardiovascular instability
Non-judgmental clinical spaces.
Guardians are more likely to disclose what they know — and what they don’t know — when they don’t fear blame or punishment. That transparency directly improves animal outcomes.
As psychedelic-branded products become more common, veterinary professionals will increasingly be on the front lines of unintended exposure. Caution, curiosity, and clear communication are essential — especially when labels cannot be trusted.
This isn’t about panic or prohibition. It’s about recognizing risk in a changing landscape and supporting animals — and their people — with calm, informed care.
Increase your clinical preparedness
Just curious or ready to up your clinical game? Check out our series of educational courses. Whether you are a curious animal guardian, a responding veterinary clinician, or any of our community members in between - these educational resources are for you.
—
VeterinaryPsy explores harm reduction, One Health, and the human–animal bond at the intersection of veterinary medicine and emerging social trends.
About the Author
Steven J Kruzeniski, BSc, DVM
Dr. Steven Kruzeniski is a companion animal veterinarian with further education and passion for Planetary Health, Human Support, Indigenous Wisdom and Psychedelic Assisted Therapies.
For over a decade, Dr. Steve has been living and working across The Americas, Africa and Asia and currently resides in the Sacred Valley of Peru. His work combines social veterinary service & educational advocacy for animal welfare; support of veterinary professional wellbeing; and Psychedelic Harm Reduction for both humans and animals.
Dr. Steve has extensive experience as a clinician & instructor to veterinary professionals and students from around the world. He is passionate about human support in relation to animal ownership. Caring for a pet, and the resulting human-animal bond, is powerful responsibility and deserves respectful consideration as it relates to emotional wellbeing for everyone.
Decisions relating to animal health can be challenging, especially as they relate to a pets emotional needs and emotional intersections with other members of the family-unit. Dr. Steve strive to provide an environment for in depth discussion relating to animal wellbeing and exploration of how animal health decisions may affect the entire family-unit.
